drugset / Trial / NCT01984229

A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers

NCT01984229

Phase 1 Completed 23 enrolled Hoffmann-La Roche
Non-randomizedCrossoverOpen-labelTreatment

Summary

This open-label study will investigate whether multiple oral doses of posaconazole affect the single dose pharmacokinetics of alectinib in healthy volunteers.

Timeline

Start
2013-12
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Alectinib Small molecule 40 mg Oral
Subject Posaconazole Small molecule 400 mg Oral

Indications

No indication recorded.